Pfizer’s Dacomitinib And More Biosimilar Hopefuls Among New EMA Filings

 
• By Neena Brizmohun and Ian Schofield
  
Samples of medicines, tablets, capsules, vitamins, and placebo
Eight new marketing applications are on the EMA's latest list of products for review
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet